Table 2.
C. perfringens strain | Compound | Wild type | Norfloxacin-resistant | Ciprofloxacin-resistant | Gatifloxacin-resistant |
---|---|---|---|---|---|
VPI | Sodium chloride | 1% | 1% | 4%∗b | 2% |
NCTR | 2% | 2% | 2% | 1% | |
3626 | 2% | 2% | 2% | 2% | |
13124 | 6.5% | 4%* | 6% | 2%* | |
| |||||
VPI | Urea | 6% | 6% | 4% | 4%* |
NCTR | 6% | 4% | 3% | 2%* | |
3626 | 3% | 4% | 4% | 2% | |
13124 | 7% | 6% | 7%∗∗c | 6%* | |
| |||||
VPI | Sodium lactate | 1% | 1% | 2%* | 2% |
NCTR | 2% | 1% | 2%** | 2% | |
3626 | 1% | 2% | 2% | 2% | |
13124 | 6% | 4%* | 5%* | 3%** | |
| |||||
VPI | Sodium nitrite | 60 mM | 40 mM* | 40 mM* | 60 mM |
NCTR | 60 mM | 40 mM | 60 mM** | 20 mM* | |
3626 | 20 mM | 40 mM | 40 mM | 20 mM | |
13124 | 60 mM | 60 mM | 60 mM | 40 mM* |
aThe percent (%) or mM value indicates the concentration in which the strain would grow. b∗Statistically significant differences are marked by asterisks (P < 0.05). c∗∗Better growth was observed for the mutant than for the wild type (P < 0.05) at the concentrations marked by double asterisks.